rs12901187
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000103.4(CYP19A1):c.-38-14390C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 152,074 control chromosomes in the GnomAD database, including 9,693 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 9693 hom., cov: 33)
Consequence
CYP19A1
NM_000103.4 intron
NM_000103.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.398
Publications
5 publications found
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.426 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP19A1 | NM_000103.4 | c.-38-14390C>T | intron_variant | Intron 1 of 9 | ENST00000396402.6 | NP_000094.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.329 AC: 49920AN: 151956Hom.: 9694 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
49920
AN:
151956
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.328 AC: 49925AN: 152074Hom.: 9693 Cov.: 33 AF XY: 0.328 AC XY: 24349AN XY: 74332 show subpopulations
GnomAD4 genome
AF:
AC:
49925
AN:
152074
Hom.:
Cov.:
33
AF XY:
AC XY:
24349
AN XY:
74332
show subpopulations
African (AFR)
AF:
AC:
4998
AN:
41504
American (AMR)
AF:
AC:
4587
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1655
AN:
3470
East Asian (EAS)
AF:
AC:
2167
AN:
5168
South Asian (SAS)
AF:
AC:
1473
AN:
4816
European-Finnish (FIN)
AF:
AC:
4536
AN:
10540
Middle Eastern (MID)
AF:
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29249
AN:
67978
Other (OTH)
AF:
AC:
726
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1610
3220
4830
6440
8050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1019
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.